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by ELISAs for complement component 5a (C5a), tumor necrosis factor (TNF) and extracellular histones.
In vivo results were completed by in vitro experiments with human cardiomyocytes treated with TNF
and extracellular histones. The influence of histones and human plasma after fracture on isolated human
polymorphonuclear leukocytes (PMNs) was investigated. An elevation of TNF, C5a and extracellular
histones after long bone fracture was measured. Moreover, the appearance of systemic troponin I levels
was observed and structural changes in connexin 43 and desmin were detected. Further, the presence of
TNF lead to elevation of reactive oxygen species, troponin I release and histone appearance in supernatant
of human cardiomyocytes. Incubation of human PMNs with histones and plasma of patients after fracture
lead to formation of neutrophil extracellular traps. Present results suggest that structural alterations in
the heart might be consequences of the complement activation, the release of extracellular histones and
the systemic TNF elevation in the context of a long bone fracture.
DOI: https://doi.org/10.1097/SHK.0000000000001536





Weber, Birte; Lackner, Ina; Knecht, Deborah; Braun, Christian Karl; Gebhard, Florian; Huber-Lang,
Markus; Hildebrand, Frank; Horst, Klemens; Pape, Hans-Christoph; Ignatius, Anita; Schrezenmeier,
Hubert; Haffner-Luntzer, Melanie; Kalbitz, Miriam (2020). Systemic and Cardiac Alterations After Long








































Copyright © 2020 by the Shock Society. Unauthorized reproduction of this article is prohibited.
Shock, Publish Ahead of Print 
DOI: 10.1097/SHK.0000000000001536 































these authors are equally contributed 
 
1 
Department of Traumatology, Hand-, Plastic- and Reconstructive Surgery, Center of Surgery, 
University of   Ulm, 89081 Ulm, Germany  
2
 Institute of Clinical and Experimental Trauma Immunology, University Hospital of Ulm, 
89081 Ulm, Germany 
3
 Department of Orthopaedic Trauma, RWTH Aachen University, 52062 Aachen, Germany  
4
 Department of Trauma, University Hospital of Zurich, 8091 Zurich, Switzerland 
5
 Institute of Orthopedic Research and Biomechanics, University of Ulm, 89081 Ulm, 
Germany 
6
 Institute of Transfusion Medicine, University of Ulm and Institute of Clinical Transfusion 
Medicine and Immunogenetics Ulm, German Red Cross Blood Transfusion Service Baden-
Württemberg – Hessen and University Hospital Ulm, 89081 Ulm, Germany 
 
Corresponding author: 
Miriam Kalbitz, MD 
University of Ulm Medical School 
Department of Traumatology, Hand-, Plastic- and Reconstructive Surgery 
Center of Surgery, Albert-Einstein-Allee 23, 89081 Ulm, Germany 
Phone: 0049 (731) 50054561 
Fax: 0049 (731) 50054502; Email: miriam.kalbitz@uniklinik-ulm.de 
 
Copyright © 2020 by the Shock Society. Unauthorized reproduction of this article is prohibited.
Competing interests: The authors declare no conflict of interests 
 
Funding: This work was conducted in the framework of the CRC 1149 funded by the Deutsche 
Forschungsgemeinschaft (DFG, German Research Foundation) – Project number 251293561. 
Furthermore, funding for the porcine experiments was granted by the AO Project no. S-14-14P. 
 
Abstract 
The purpose of this study was to reveal possible consequences of long-bone fracture on cardiac 
tissue and to analyze the role of systemically elevated danger associated molecular patterns, 
complement anaphylatoxins and cytokines. Blood samples of mice, pigs, and humans after a 
fracture were analyzed by ELISAs for complement component 5a (C5a), tumor necrosis factor 
(TNF) and extracellular histones. In vivo results were completed by in vitro experiments with 
human cardiomyocytes treated with TNF and extracellular histones. The influence of histones 
and human plasma after fracture on isolated human polymorphonuclear leukocytes (PMNs) was 
investigated. An elevation of TNF, C5a and extracellular histones after long bone fracture was 
measured. Moreover, the appearance of systemic troponin I levels was observed and structural 
changes in connexin 43 and desmin were detected. Further, the presence of TNF lead to 
elevation of reactive oxygen species, troponin I release and histone appearance in supernatant 
of human cardiomyocytes. Incubation of human PMNs with histones and plasma of patients 
after fracture lead to formation of neutrophil extracellular traps. Present results suggest that 
structural alterations in the heart might be consequences of the complement activation, the 
release of extracellular histones and the systemic TNF elevation in the context of a long bone 
fracture.  
Keywords: early total care, damage control orthopedics, troponin I, HFABP, complement 
system, connexin43, polymorphonuclear leukocytes 
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Introduction 
Physical traumata are an increased burden for the society (1) and reflect a major challenge for the 
future. Despite direct cardiac damage after physical trauma, there is rising evidence for trauma-
induced secondary cardiac structural and functional damage (2,3). After multiple trauma in pigs, 
a functional and structural damage of the heart has been described in previous studies (4); as well 
as a linkage between systemic cardiac troponin I levels of multiple injured patients and the 
corresponding survival (5). Further, an association between hip fracture and the appearance of 
coronary heart disease was made (6,7). Therefore, the question arises whether and how single 
long bone fractures may affect the heart. 
In the present study, different animal models and human samples were analyzed to investigate 
whether a long bone fracture and the inflammatory consequences are linked to cardiac 
alterations. In particular the role of tumor necrosis factor (TNF), complement component 5a 
(C5a) and extracellular histones after fracture were investigated. TNF is well-known to be 
elevated after fracture (8,9) and to be cardio-depressive (10,11). TNF induces apoptosis in 
cardiomyocytes and lead to cardiac dysfunction in different models. (12–14,10). Activation of 
the complement system, especially C5a caused cardiomyocyte dysfunction during sepsis (15). 
Likewise, after fracture the complement system has been shown to be activated (16,17). 
Furthermore, C5a leads to an activation of neutrophil granulocytes, which are able to form 
neutrophil extracellular traps (NETs) (18,19), containing DNA and extracellular histones. 
Extracellular histones are described as a mediator of septic cardiomyopathy. Histones caused 
disequilibrium in the redox status and intracellular [Ca
2+
]i levels in cardiomyocytes (CMs) and 
disturbed functional and electrical responses of hearts perfused with histones and induce defects 
in mitochondrial function (20). Therefore, the NET-formation by neutrophils in patients with 
bone fracture will be investigated in regard of its role in amplifying systemic release of DAMPs 
and consequently causing organ damage. 
 
Materials and Methods  
Mice: 
All animal experiments were performed according to the international regulations for the care and 
use of laboratory animals and were approved by the responsible government authority (No. 1096 
Copyright © 2020 by the Shock Society. Unauthorized reproduction of this article is prohibited.
and 1149, Regierungspräsidium Tübingen, Germany). They were performed according to the 
guidelines of the Federation of European Laboratory Animal Science Association (FELASA). 
Mice received either sham treatment or femur osteotomy for 6 and 24 hrs, respectively. For the 
respective groups, 5-7 animals were used. Briefly, an osteotomy (0.4 mm) was performed at the 
mid-shaft at the right femur of 12 weeks old, male C57BL/6J-Mice, purchased from Charles River 
(Sulzfeld, Gemany). General anesthesia was conducted with 2% isoflurane, mice received 
tramadol for analgesia. The femur fracture was stabilized by using an external fixator (RISystem, 
Davos, Switzerland. Blood plasma from mice was collected at the end of the experiments, 6 and 24 
hrs after fracture or sham procedure, by puncture of the heart under deep anesthesia. 1 ml whole 
blood was collected, centrifuged at 4000 ×g for 10 min and plasma was stored at −80 °C. Details of 
the animal experiment and sample collection were already published in Kroner, et al. (2017) (21) 
and Kovtun, et al. (2016) (22). 
 
Pigs: 
Animals and Anesthesia: All procedures conformed to the Society of Laboratory Animal Science 
(GV-SOLAS) as well as the National Animal Welfare Law and gained approval from the 
responsible government authority ("Landesamt für Natur, Umwelt und Verbraucherschutz": 
LANUV-NRW, Germany: AZ TV-No.: 84-02.04.2014.A265). They were performed according to 
the guidelines of the Federation of European Laboratory Animal Science Association (FELASA). 
Animal experiments adhere to the Animal Research: Reporting of In Vivo Experiments 
(ARRIVE) guidelines for reporting animal research. In the interest of limiting animal numbers, 
the samples were obtained from a recently conducted prospective randomized experimental study 
performed by the TREAT Research Group. The model has been previously described in detail by 
Horst.et, al (23). Briefly, 11 12-16 weeks old male pigs with a mean body weight of 30 ± 5 kg (Sus 
scrofa dormestica, Tierzucht GmbH Heinrich, Heinsberg, Germany) were included in the study. 
Anesthesia was induced and maintained during the study period of 72 hrs with propofol (1-2 mg/kg 
body weight). The pigs were orotracheally intubated and ventilation was conducted in biphasic 
positive airway pressure (BiPAP) mode in a lung protective ventilation (6-8 ml/kg body weight). 
Vital parameters were monitored by electrocardiographic (ECG) recordings and ECG-
synchronized pulse oximetry. Fluids were administered by continuous crystalloid infusion 
(Sterofundin ISO; 2 ml/kg body weight /h). 
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Fracture surgery: Pigs underwent a femur fracture (n=8) or sham procedure (n=3). The Sham 
procedure included anesthesia but no femur fracture. The fracture group (n=8) was randomized in 
two therapy arms (n=4); external fixation of the femur fracture corresponding to damage control 
orthopedics (DCO) or femoral nailing appropriate to early total care (ETC) principles.  
 
Sample collection: Whole venous blood samples, containing all physiological blood components 
were collected from V. femoralis at baseline (BL) as well as 1.5, 3.5, 5.5, 24, 48 and 72 hrs after 
fracture. At each time point, 6 ml whole venous blood was collected from the pigs. Blood loss was 
adjusted adequately by continuous crystalloid administration (Sterofundin ISO; 2 ml/kg body 
weight /h). Samples were kept on ice and serum was obtained by centrifugation (2,000 x g for 15 
min at 4°C). After centrifugation, serum was removed and stored at -80°C until analysis. Heart 
tissue of left ventricles was obtained 72 hrs after multiple trauma and fixed with 4 % formalin 
followed by embedding in paraffin. 
 
Humans: 
Human blood sample collection was approved by the Ethical Committee of the University Medical 
Center Ulm (No. 438/15) as recently published (24) and was in accordance with the declaration of 
Helsinki. All enrolled patients signed the written informed consent form themselves or written 
informed consent was obtained from the nominated legally authorized representatives on the behalf 
of participants in accordance with ethical standards. All methods were performed in accordance to 
the ethical guidelines of the Ethical Committee of the University Medical Center Ulm (No. 
438/15). 
In total, 26 patients (age: 32–97 years, mean: 75 years) with metaphyseal/diaphyseal fractures of 
long bones (femur, tibia, humerus, radius, ulna) treated surgically at the University Medical 
Center Ulm between January 2016 and January 2018 were included. Exclusion criteria were 
polytrauma, pregnancy, bone diseases except primary osteoporosis, intake of bisphosphonates or 
parathyroid hormone, rheumatoid arthritis, open fractures grade 3 or 4 according to Tscherne and 
Oestern, hepatic or nephritic insufficiency, cancer, intake of steroids, intake of 
immunosuppressive medication, chemotherapy in the last 3 months and artificial ventilation after 
surgery. In further subgroup analyses, patients with femur fracture (AO-31 A1/A2/A3/B2; n = 
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19) were assigned to two groups at d0: male fracture patients (n = 6, age: 32–97 years, mean: 69 
years) and female fracture patients (n = 13, age: 57–87 years, mean: 78 years). Furthermore, 20 
healthy volunteers (10 males aged 24–57, mean: 37; 10 females aged 27–87 years, mean: 47 
years) donated one blood sample each as controls. The collective of the analyzed serum was 
published previously by Fischer et al. (24). Peripheral venous blood was obtained from each 
patient at the day 0 after fracture event. Additionally, blood from seven patients was obtained at 
day 14 after fracture. Blood samples were centrifuged to get serum, which was stored at -80 °C 
until analysis. Details of sample collection and the patient cohort were previously published by 
Fischer, et al (2018) (24). 
 
ELISAs  
Serum and plasma samples were analyzed using ELISA kits according to the manufacturer’s 
instructions. Histones in mice plasma, pig serum and human plasma were measured by using a cell 
death detection ELISA kit (Hoffmann-La Roche, Indianapolis, IN, USA). A histone mixture 
(containing H2, H2A, H2B, H3, H4) (Sigma, St.-Louis, Missouri, USA) was used to establish a 
standard curve. Cardiac troponin I concentrations in mouse plasma, pig serum samples, human 
plasma and supernatant of human cardiomyocytes were measured by using species-specific 
ultrasensitive troponin-I ELISA kits (Life Diagnostics, West Chester, PA, USA) and cardiac 
troponin I human simple Step ELISA Kit (Abcam, Cambridge, UK). C5a was measured in patient 
and mouse plasma by using a C5a ELISA (DRG Diagnostics, Marburg, Germany; R&D Systems, 
McKinley, MN, USA). IL-6 was measured in plasma/serum of mice/humans with fracture by IL-6 
ELISA (R&D Systems, McKinley, MN, USA). TNF concentrations were measured in mice plasma 
samples by TNF ELISA (R&D Systems, McKinley, MN, USA). Human TNF was detected in 
serum of fracture patients measured by TNF ELISA (Abcam, Cambridge, UK). 
Immunohistochemistry:  
For immunohistochemistry porcine, formalin-fixed left ventricles were used. For complement 
component 5a receptor (C5aR1) staining polyclonal Rabbit anti CD88/C5aR1 (Acris Antibodies, 
Herford, Germany) was used as primary antibody. For Connexin (Cx43) staining rabbit anti-pig 
Cx43 (Cell Signaling Technology, Danvers, MA, USA) was used. Nitrotyrosine staining was 
performed using anti-nitrotyrosine (Merckmillipore, Darmstadt, Germany). Dako REAL Detection 
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System (Dako, Glostrup, Denmark) was used as secondary system. Signal density was measured in 
9 randomly chosen, distinct fields of vision from each slide using an Axio ImagerM.1 microscope 
and the Zeiss AxioVision software 4.9 (Zeiss, Jena, Germany). Results are presented as mean 
density of each group (arbitrary units).  
 
Confocal Imaging 
For the confocal imaging, the left ventricles of pigs 72 hrs after fracture (DCO and ETC) (n=8) or 
after sham treatment (n=3) were analyzed. Therefore, formalin fixed and paraffin embedded heart 
tissue from left ventricles were used from the pigs.  
For α-actinin-2 staining rabbit anti-α-actinin (clone N1N3) (GeneTex, Ivine, CA, USA) was used 
as primary and goat anti-rabbit (AF-488) as secondary antibody (Jackson Immuno research 
Laboratories, West Grove, PA, USA). For desmin staining mouse anti-desmin (GeneTex, Irvine, 
CA, USA) was deployed as primary and goat anti-mouse (AF-647) as secondary antibody (Jackson 
Immuno Research Laboratories, West Grove, PA, USA). Following staining sections were 
mounted with ProLong Gold Antifade Reagent (Invitrogen, Carlsbad, CA, USA). Confocal 
imaging was performed using Leica SP8 (Leica microsystems, Wetzlar, Germany). Evaluation of 
fluorescence-intensity was conducted by the Software Image J x1 (25). Terminal deoxynucleotidyl 
transferase dUTP nick end labeling (TUNEL) staining was performed by using CF 488 TUNEL 
Apoptosis Detection Kit (Biotium, Fremont, CA, USA). A counterstain with Höchst 33342 
(Sigma, Darmstadt, Germany) was done. Results of TUNEL positive nuclei were presented in 
percentage of whole nuclei number.  
 
Determination of RNA expression of C5aR1 in pig left ventricle homogenates by Real-time 
Quantitative PCR Analysis 
Total RNA was isolated from pig heart homogenates using TRIZOL (Life Technologies, Carlsbad, 
CA, USA) according to manufacturer’s instructions. cDNA was then obtained by using 
SuperScript IV VILO Master Mix with ezDNAse enzyme (Thermo Fisher, Waltham, MA, 
USA) and was then amplified by using PowerUp SYBR Green Master Mix (Life 
Technologies, Carlsbad, CA, USA).  Amplification was performed by using Quant Studio 3 
(Applied Biosystems, Waltham, MA, USA). mRNA expression of the respective genes was 
normalized to GAPDH expression. Calculation of the relative quantitative mRNA expression was 
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done with the cycle threshold method
ΔΔCt 
algorithm. C5aR1-Primer: Forward: 5‘-
AGAATATGGACCCCATGGTTG-3‘, Reverse: 5‘-GTTCTGGAAGAGGCATCCAC-3‘ 
 
In vitro incubation of cardiomyocytes (CMs) with inflammation-cocktail (IF-C) and TNF   
Human cardiomyocytes (iPS) (Cellular Dynamics, Madison, WI, USA) were cultured for 10 days 
at 37°C and 7% CO2 in iCell medium (Cellular Dynamics, Madison, WI, USA). After 10 days an 
incubation with either inflammation-cocktail (IF-C), including 500 ng/ml C3a, 10 ng/ml C5a, 250 
pg/ml IL-1, 500 pg/ml IL-6, 150 pg/ml IL-8 and 10 ng/ml TNF, or with only 250 pg/ml TNF (at 
37°C and 7% CO2) for 6 hrs followed. After 6 hrs, supernatant and cell lysates were frozen at -
20°C. Supernatant was used to measure extracellular histones detected by cell death detection 
ELISA kit (Hoffmann-La Roche, Indianapolis, IN, USA) and to investigate troponin I 
concentration by using human troponin I simple step ELISA kit (Abcam, Cambridge, UK). To 
assess caspase-3 in treated cardiomyocytes, Caspase-Glow 3/7 Assay (Promega, Madison, WI, 
USA) was used. Cytosolic reactive oxygen species (ROS) were measured by immunofluorescence 
by using CellROX Deep Red Reagent (Life Technologies, Carlsbad, CA, USA). Cell lysates were 
used to isolate mRNA for qPCR measurements. cDNA was then obtained by using SuperScript 
IV VILO Master Mix with ezDNAse enzyme (Thermo Fisher, Waltham, MA, USA) and was 
then amplified by using PowerUp SYBR Green Master Mix (Life Technologies, Carlsbad, CA, 
USA). Amplification was performed by using Quant Studio 3 (Applied Biosystems, Waltham, 
MA, USA). mRNA expression of the respective genes was normalized to GAPDH expression. 
Calculation of the relative quantitative mRNA expression was done with the cycle threshold 
method ΔΔCT algorithm. The following primers were utilized: for mRNA expression of IL-1ß 
forward 5´-GCAAGGGCTTCAGGCAGGCCGCG-3´ and reverse 5´-
GGTCATTCTCCTGGAAGGTCTGTGGGC-3´; for NLRP3 mRNA expression forward 5´-
CTTCTCTGATGAGGCCCAAG-3´ and reverse 5´-GCAGCAAACTGGAAAGGAAG-3´; 
mRNA of C5aR1 forwards 5´-GGAGACCAGAACATGAACTCCTT-3´ and reverse 5´-
ATCCACAGGGGTGTTGAGGT -3´; for C3aR mRNA expression forwards 5´-
AGACAGGACTCGTGGAGACA-3´ and reverse 5´-AGACGCCATTGCTAAACTTCAAA-3´.  
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Mitochondrial Respiration with Seahorse XFe96 Analyzer 
Human cardiomyocytes (iPS) (Cellular Dynamics, Madison, WI, USA ) were seeded in special 
Seahorse XFe96 cell culture plates (Agilent Technologies, Santa Clara, CA, USA) and were 
cultured for 10 days in iCell maintenance medium (Cellular Dynamics, Madison, WI, USA) at 
37°C and 7% CO2. After the cultivation, cells were treated either with 250 pg/ml TNF or with the 
above mentioned IF-C for 6 hrs at 37°C and 7% CO
2
. After exposure of cells to TNF or IF-C, 
mitochondrial respiration was measured. Mitochondrial respiration was measured by using the 
Seahorse XFe96 Analyzer (Agilent Technologies, Santa Clara, CA, USA) and the Seahorse XF 
Cell Mito Stress Test Kit (Agilent Technologies, Santa Clara, CA, USA). Immediately after the 
experiment, cells were fixed with 4% formalin at 4°C overnight. Then cells were stained with 
0.2% Janus-Green solution, washed and resolved with 0.5 M hydrochloric acid. OD was 
measured at 630 nm. The oxygen consumption rate (OCR) values were normalized to the OD 
630 nm values, respectively. Results were evaluated using Seahorse Wave 2.4 software (Agilent 
Technologies, Santa Clara, CA, USA). 
  
In vitro incubation with histones 
Human cardiomyocytes (iPS) (Cellular Dynamics, Madison, WI, USA) were cultured for 10 days 
at 37°C and 7 % CO2 in iCell medium (Cellular Dynamics, Madison, WI, USA). After 10 days an 
incubation with 100 µg/ml histones (Sigma, St Louis, Missouri, USA) for 6 hrs, 12 hrs and 24 hrs 
followed. Control cells were incubated with PBS in iCell medium. Troponin I was measured by 
human cardiac troponin simple step ELISA kit (Abcam, Cambridge, UK) in supernatant of treated 
cardiomyocytes.  
 
Isolation and treatment of human polymorphonuclear leucocytes (PMNs)  
Human blood sample collection was approved by the Ethical Committee of the University Medical 
Center Ulm (local Approval no 94/14). Human blood plasma was used to isolate human PMNs 
from healthy control patients.  
For PMN isolation 30 ml human whole blood was collected with S-Monovette, coated with 3.2% 
citrate (Sarstedt, Nümbrecht, Germany). Whole blood was mixed with 0.9% NaCl solution 
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(Fresenius Kabi, Bad Homburg, Germany). Afterwards, whole blood was layered at Ficoll-Paque
 
Plus (GE Healthcare, Uppsala, Sweden) and was centrifuged for 30 min with 340 x g at room 
temperature. Cells from whole blood, containing also leukocytes were separated by density 
gradient during centrifugation. After centrifugation, supernatant was discarded and the pellet, 
containing the leukocytes was collected. The pellet was incubated for 30 min with Dextran (from 
Leuconostoc spp., Sigma, St. Louis, MO, USA). After incubation, pellet was discarded and 
supernatant was filled up with 0.9% NaCl (Fresenius Kabi, Bad Homburg, Germany) and was once 
again centrifuged for 5 min with 340 x g. After this centrifugation, the supernatant was discarded, 
the pellet was lysed by adding double-distilled water and was refilled afterwards with 2.7% NaCl 
solution (Sigma Aldrich, St. Louis, MO, USA). Afterwards, another centrifugation step followed 
for 5 min with 340 x g. Then, the supernatant was discarded and the pellet, containing the 
neutrophils was resuspended in Hanks’ balanced salt solution (HBSS, Sigma Aldrich, St. Louis, 
MO, USA.) Isolated neutrophils were cultured with DMEM (Gibco, Paisley, Scotland, UK), 
supplemented with 10% fetal bovine serum (FBS), 1% L-Glutamin and 1% penicillin/streptomycin 
for 1.5 hrs. Isolated neutrophils were incubated with a mixture of histones (Sigma, St.-Louis, 
Missouri, USA). For Figure 6B histone-concentrations of 0.05, 0.5, 1, 10 and 20 µg/ml and LPS- 
concentrations of 5, 10, 20 and 50 µg/ml were used and incubated for 2 hrs.  
Isolated PMNs were also incubated with serum from patients with a fracture or from healthy 
controls for 2 hrs. The used serum samples from fracture patients as well as from healthy controls 
were randomly selected from the present serum collective of the study. Additional propidium 
iodide (Sigma, St. Louis, Missouri, USA) and Hoechst was added to the wells for staining 
extracellular DNA/NETs. After incubation PMNS were washed twice with PBS, were fixed with 4 
% Formalin and were mounted with ProLong Gold Antifade Reagent (Invitrogen, Carlsbad, CA, 
USA). The whole experiment was repeated 3 times.  
Statistical procedures 
All values were expressed as means ± SEM. Data were analyzed by one-way ANOVA followed by 
Dunnett’s, Tukey’s or Holm-Sidak’s multiple comparison test. p≤0.05 was considered statistically 
significant. GraphPad Prism 7.0 software was used for statistical analysis (GraphPad Software Inc., 
San Diego, CA, USA).  
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Results 
Systemic inflammation and release of extracellular histones after fracture in mice, pigs and 
humans (Figure 1) 
In order to determine systemic inflammation after long bone fracture, the systemic release of the 
inflammatory and cardio-depressive mediators C5a, C3a, TNF and of extracellular histones were 
measured in mouse, pig and human blood samples. Mice subjected to femur fracture 
demonstrated increased systemic complement activation by enhanced release of C5a (Figure 1a) 
and of C3a (Figure 1b) compared to sham treated animals 6 hrs after fracture. Systemic IL-6 
concentrations in blood samples of mice 6 hrs after fracture were elevated significantly, whereas 
systemic TNF was enhanced slightly but not significantly (Figure 1c/d). Extracellular histone 
concentration in plasma was elevated 24 hrs after fracture in mice (Figure 1e). In pigs subjected 
to femur fracture, extracellular histones in serum samples were significantly increased 1,5 and 3 
hrs after trauma compared to baseline (Fig 1f). In humans, extracellular histones (Fig 1g) were 
increased systemically compared to healthy controls 0 and 14 days after meta/diaphyseal fracture 
of long bones. Further, after fracture C5a (Figure 1i) and TNF (Figure 1h) were slightly elevated 
systemically at day 0 and 14 days after fracture compared to healthy controls.  
 
Hemodynamic alterations in pigs after fracture (Table 1) and systemic Troponin I concentrations 
in pigs and humans after fracture (Figure 2) 
Since mice, pigs and humans showed increased levels of inflammatory mediators after long bone 
fracture, which were all previously shown to be cardio-depressive, cardiac injury was analyzed 
in the respective species.  In order to estimate cardiac injury after fracture in pigs and humans, 
troponin I as specific marker for cardiac cell damage was assessed at different time points after 
trauma (Figure 2). Cardiac troponin I was elevated systemically in pooled serum from pigs of 
both treatment groups (DCO and ETC) 1.5 and 3 hrs after trauma compared to baseline (Figure 
2a). The troponin I release could not be explained by apoptosis of cardiac cells: no differences in 
apoptotic positive cardiomyocytes were measured between sham and fracture animals (Figure 
2b). Furthermore, cardiac troponin I in human plasma was detected after fracture. Here an 
elevation at the day of fracture (day 0) was measured in plasma of patient with fracture compared 
to healthy controls (Figure 2c). The systemic troponin I release from humans after fracture was 
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independent of age and there was no statistic correlation between systemic troponin I release and 
age (R
2
=0.003) (2 d).   
Pigs showed increased systemic inflammation as well as the presence of the myocardial injury 
marker troponin I, therefore the hemodynamic parameters of the animals were analyzed after 
long bone fracture. To determine the hemodynamic alterations in pigs after long bone fracture, 
the heart rate (HR), the mean arterial pressure (MAP) as well as the systolic RR-interval were 
measured by electrocardiographic (ECG) recordings (Table 1). The data from the pigs of both 
treatment groups (DCO and ETC) were combined for the analysis (n=12). The HR decreased 
significantly during the observation period. Moreover, the MAP as well as the systolic RR-
interval increased significantly over the observation time.  
 
Structural alterations in the porcine heart after long bone fracture: α-actinin, desmin and 
translocation of Cx43 (Figure 3) 
Since pigs showed hemodynamic alterations, the left ventricular expression of the cardiac 
structure proteins α-actinin and desmin were analyzed. Both structure proteins are associated 
with impaired cardiac function after trauma. The expression of α-actinin in CMs was increased 
72 hrs after fracture, followed by DCO treatment compared to sham procedure (Figure 3a), 
which was determined by fluorescence intensity measurement. Comparable results showed the 
measurement of fluorescence intensity of desmin staining of the left ventricles. The expression of 
desmin was increased in the ETC compared to sham treated animals (Figure 3b).  
Left ventricular alterations of the gap junction protein Cx43 are associated with severe 
arrhythmia. Therefore, alterations of the left ventricular expression of Cx43 after long bone 
fracture were analyzed in pigs. To determine whether gap junction proteins in the heart were 
altered after fracture immunohistochemistry staining of Cx43 gap junction protein in left 
ventricular tissue sections was performed. In sham treated animals Cx43 was located in 
intercalated discs whereas Cx43 was translocated and scattered into the cytosol (Figure d) after 
fracture followed by DCO or ETC. No differences in total Cx43 protein expression in left 
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Local inflammation in porcine heart after long bone fracture (Figure 4) 
After trauma, the activation of the complement system is associated with impaired cardiac 
function. Since mice and humans showed increased systemic levels of the complement activation 
products C3a and C5a after long bone fracture, the left ventricular expression of the C5a receptor 
1 (C5aR1) was determined in pigs after isolated long bone fracture. There was a reduction of the 
complement receptor C5aR1 72 hrs after fracture in both treatment groups (DCO and ETC) 
compared to the sham group (Figure 4a) whereas mRNA expression of C5aR1 was not 
significant influenced by fracture in pigs, after 72 hrs (Figure 4b).  
 
In vitro influence of inflammatory mediators and TNF on human cardiomyocytes (Figure 5 and 
6) 
Mice, pigs and humans showed increased systemic levels of inflammatory mediators after 
isolated long bone fracture, therefore the effects of the TNF as well as of a defined 
inflammation-cocktail were analyzed on human cardiomyocytes in vitro. In presence of 
inflammation-cocktail and in presence of TNF the mitochondrial respiration was impaired 
compared to control cells (Figure 5a). The mitochondrial basal respiration (Figure 5b), the 
mitochondrial spare respiratory capacity (Figure 5c) as well as the mitochondrial maximal 
respiration (Figure 5d) were significantly decreased in the cells when exposed to inflammation-
cocktail and to TNF. Furthermore, the amount of cytosolic ROS significantly enhanced in the 
presence of inflammation-cocktail (Figure 5e), compared to the control cells. The mRNA 
expression of IL-1 significantly decreased in presence of inflammation-cocktail (Figure 5f), 
whereas mRNA expression of NLRP3 inflammasome significantly enhanced in the cells (Figure 
5g), compared to the control cells. 
Human CMs were incubated with recombinant human TNF for 6 hrs. Here, troponin I 
concentrations in supernatants were significantly increased in presence of TNF (Figure 6a). 
Activity of caspase 3 indicating CM apoptosis was not elevated in presence of TNF (Figure 6b). 
Whereas, extracellular histone concentration in supernatant was significantly elevated in 
presence of TNF (Figure 6c). Further, TNF was associated with reduced mRNA expression of 
IL-1ß in CMs compared to controls after 6 hrs (Figure 6d), whereas mRNA expression of NLRP3 
in presence of TNF was increased (Fig 6e). Neither the expression of Cx43 (Figure 6f) nor 
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C5aR1 (Figure 6g) was affected by the presence of TNF of human CMs. Though, cytosolic ROS 
was elevated in CMs in presence of TNF compared to CM in absence of TNF (Figure 6h). 
 
Effects of extracellular histones (Figure 7) 
Pigs and humans showed enhanced systemic levels of extracellular histones, consequently we 
analyzed the ability of human PMNs to make NET-formation in presence of extracellular 
histones, amplifying the inflammatory response after isolated long bone fracture. The incubation 
of human PMNs with histones led to NET-formation in a dose dependent manner, measured by 
immunofluorescence of extracellular DNA (Figure 7a), whereas the positive control was 
accomplished by LPS-incubation. Additionally, incubation of PMNs with plasma of patients 
with fracture resulted in a significant increase in extracellular DNA compared to PMNs treated 
with plasma from healthy controls (Figure 7b). Incubation of human CMs with histone mixture 
for 6 hrs, 12 hrs and 24 hrs was associated with increased troponin I concentrations in 
supernatant compared to controls (Figure 7c).  
 
Discussion 
In this study, we showed a systemic elevation of different inflammatory biomarkers and DAMPs, 
such as C5a, TNF and extracellular histones after long bone fracture in the species human, pig 
and mouse. Moreover, we observed hemodynamic and structural cardiac alterations in pigs, 
which might indicate for a secondary cardiac damage after isolated femur fracture. 
Structural alterations of cardiac tissue after fracture were indicated by an increased -actinin 
expression in pig hearts after femur fracture, with DCO treatment. We previously showed 
alterations in cardiac -actinin expression in pigs after experimental polytrauma, which was 
associated with impaired cardiac function. -actinin is linked with L-type Ca2+- channels and 
reacts as responder to mechanical stretch by hemodynamic adaption (26). Interestingly, Z-disc 
associated proteins like -actinin are not only altered due to direct mechanical trauma on the 
heart as shown after multiple trauma in pigs, but also to fracture. Alterations in -actinin 
expression might be to systemic inflammation after fracture. Furthermore, the expression of 
desmin increased in the present study in porcine heart tissue, which was previously shown after 
experimental polytrauma in pigs (4). Cardiac desminopathies lead to cardiomyopathy, 
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conduction defects and to arrhythmias (27,28). Desminopathies were associated with impaired 
mechanical properties of CMs and alterations of the calcium amplitude (29). Increased desmin 
concentrations were observed in guinea pigs with heart failure (30) and in mice with diastolic 
dysfunction (31). Additionally, the distribution and function of the ryanodine receptor is affected 
by modification of desmin (32). Alterations in cardiac desmin expression might be also to 
systemic inflammation. TNF was previously described to induce the cleavage of desmin by 
caspase-6, leading to a loss of localization of desmin at the intercalated discs of CMs (33). 
Moreover, remodeling of gap junction proteins and re-localization of Cx43 were described in a 
mouse model of desmin-related cardiomyopathy (34). In the present study, pigs showed a 
likewise a translocation of Cx43 from the intercalated discs into the cytosol of the CMs after 
isolated long bone fracture. Endocytosis of Cx43 was associated with changes in spread of 
electrical activation and was further associated with arrhythmias and cardiac dysfunction (35,36). 
To our knowledge this is the first time that alterations in cardiac z-disc and gap junction proteins 
were described after an isolated long bone fracture. Summarized, in the present study pigs 
showed alterations in the left ventricular expression of cardiac structure proteins as well as in the 
localization of the gap junction protein Cx43 after isolated long bone fracture. These structural 
cardiac alterations after long bone fracture might predispose to cardiac dysfunction and to 
cardiac damage.  
Interestingly, there was evidence for cardiac injury after fracture due to increased levels of 
circulating troponin I in humans and pigs. Currently, troponin I is considered as an important 
diagnostic marker for cardiac damage in the clinical use, as well as after trauma (37). Troponin I 
has been reported to be elevated after heart contusion in 15-45% of the cases and was described 
as a reliable tool for the detection of post-traumatic heart complications, especially in 
combination with echocardiography (38,39). Enhanced systemic troponin values were associated 
with increased catecholamine requirement as well as with an increased mortality rate of the 
patients after trauma (5). In previous studies we observed systemic troponin I elevations after 
experimental polytrauma in mice and pigs (40,4) and after experimental blunt chest trauma in 
rats (41). There, enhanced troponin values were associated with impaired cardiac function and 
cardiac damage. However, here we describe a systemic, but mechanically-independent elevation 
of troponin I, which might indicate for cardiac injury after long bone fracture in humans and in 
pigs. The systemic troponin I elevation in this study was not dependent of the age of the patients. 
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The findings of this study are in contrast to them of a previous study in which no cardiac 
troponin I but skeletal troponin I was systemically detectable after soft tissue- and orthopedic 
injuries in humans (42). Nevertheless, we do not think that the release of skeletal troponin I 
distorted the present data due to highly specificity and sensitivity of the used immunoassays. The 
release of cardiac troponin I in pigs was not due to cardiomyocyte apoptosis, but might be 
induced by inflammatory cytokines. Notably, the systemic cardiac troponin I by itself is not a 
sufficient diagnostic tool for myocardial injury and patients with systemic elevated troponin I 
values must have at least one of five further diagnostic criteria for the definition of myocardial 
injury (43,44). However, no echocardiographic parameters were assessed from the patients in the 
current study but this issue has to be addressed in future studies in order to show myocardial 
injury after long bone fracture. Moreover, the systemic release of cardiac troponin I was 
described in various diseases and also in context of emotional and psychosocial stress (44–46). 
Certainly, we could not exclude stress-induced systemic release of cardiac troponin I in humans 
but we think that the release of cardiac troponin I in this study might be due to the enhanced 
inflammation after long bone fracture. This inflammatory condition of long bone fracture might 
predispose to cardiac injury.    
Based on the findings of cardiac structural alterations and of enhanced systemic cardiac troponin 
I levels in pigs after long bone fracture, we analyzed hemodynamic parameters. The HR of the 
animals decreased significantly during the observation period, whereas the MAP as well as the 
systolic RR-interval significantly increased over the observation time. These hemodynamic 
findings might indicate for cardiac functional alterations after fracture and might be further 
linked to cardiac structural changes and to cardiac injury. However, this assumption of cardiac 
dysfunction after long bone fracture has to be examined in more detail in future studies by 
echocardiographic analysis. Summarized, the occurrence of systemic troponin I as well as the 
alterations in hemodynamic parameters might indicate for cardiac injury after isolated long bone 
fracture. 
In this context the activation of the complement system may play an important role. Especially, 
the complement activation product C5a was elevated after long bone fracture in mice and 
humans in the present study. C5a and its receptors (C5aR1/2) were associated with cardiac 
dysfunction during experimental sepsis in mice (47). During ischemia/reperfusion, the 
complement system plays a critical role in endothelial transmigration, developing cardiac 
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diseases. In absence of the C5aR, the expression of matrix metalloprotease (MMP9) and junction 
adhesion molecule (JAM)-A was reduced, leading to reduced infarct size and to leucocyte 
recruitment (48). Considering other cardiac pathologies, C5a was described as powerfully 
cardio-depressive via C5aR1 interactions on the membrane of cardiomyocytes. This C5a-C5aR1 
interaction reduced cardiomyocyte contractility and the ability of relaxation, leading to reduced 
cardiac output, to amongst multi organ failure, to cardiac shock and to sudden cardiac death 
(49,20,50). Moreover, C5a triggers a massive increase of cellular ROS and Ca2+i in isolated rat 
CMs (15). Disturbed calcium homeostasis lead to impaired electrophysiological function of CMs 
and consecutively aggravated contractility (15). Increased ROS further reduced left ventricular 
function (51). Furthermore, C5a induces the release of cytokines such as IL-6 and TNF in CMs 
in vitro (52). In addition, C5a is able to induce release of extracellular histones, which is 
ameliorated in absence of C5aR1 (53,20). In vitro activation of neutrophils by C5a lead to 
enhanced histone concentrations, caused by neutrophil extracellular trap (NET)-formation (18). 
Summarized, the increased systemic C5a levels might contribute to the present cardiac 
alterations after isolated long bone fracture.  
Furthermore, in the present study, extracellular histones were elevated systemically after long 
bone fracture in mice, pigs and humans, which was also described previously after experimental 
multiple trauma (4), blunt chest trauma (41), during sepsis (20,54) and in humans after trauma 
(55). Histones were released from damaged cells after trauma (56,57), mediated by neutrophils 
and their NETs (58). Increased levels of circulating histones were associated with acute lung 
injury and with septic complications after burn injury (59). Perfusion of mouse hearts with 
extracellular histones lead to reduction of left ventricular pressure and to impaired contractility 
(20). Besides, incubation of human CMs with histones induced an increase in cytosolic ROS in a 
dose-dependent manner (60). The present data showed similarly an elevation of ROS in human 
CMs in presence of TNF. ROS induce a cytosolic calcium increase by modulating and blocking 
calcium handling proteins. Further, histones are able to interact with the phospholipid-membrane 
of cells, which lead to higher permeability and consequently to enhanced cellular calcium influx 
(61–64). Interestingly, in this study the in vitro exposure of human CMs to TNF induced 
extracellular histone release into supernatant fluids, which might additionally enhance the cardio-
depressive effects. This additional release of extracellular histones from CMs might further 
recruit other immune cells such as neutrophils, intensifying the systemic immune response. 
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Moreover, the CMs themselves are affected by the release of extracellular histones as described 
above, leading to an enhanced cardio-depressive effects, which might predispose to cardiac 
dysfunction. Summarized, increased systemic levels of extracellular histones after long bone 
fracture may affect the heart in the present study, by inducing the systemic release of troponin I.  
In the present report we demonstrated to the best of our knowledge for the first time that histones 
themselves are able to activate human neutrophils by inducing NET-formation. Neutrophils are 
present in fracture hematoma after bone injury (17). Consequently, this may result in an 
amplification of local as well as of systemic histone concentrations, which might contribute to 
compromised organ function after long bone fracture. Moreover, histone application in mice 
induces the systemic release of further cytokines such as TNF, IL-1ß, IL-6 and IL-10 (65), which 
is mediated via histone-TLRs interactions(66–70).  
Besides C5a and extracellular histones, the release of TNF after long bone fracture is well 
described and correlated with the results in the present study (8,9). The systemic release of TNF 
in the present study might also contribute to the cardiac alterations after long bone fracture. 
Blockade of TNF in experimental burn injury have been shown to improve cardiac function (71). 
Also, TNF disturbed the maximum extent of cardiac myocyte shortening in cultured rat CMs, 
which was reversible after removal of TNF (14). However, the systemic conditions after single 
long bone fracture might quite differ from them after severe polytrauma (with blunt chest 
trauma) or during sepsis. After polytrauma, the development of cardiac dysfunction is obvious 
due to the extent of systemic inflammation by the release of inflammatory cytokines and 
damages molecules, induced by severe tissue trauma. During sepsis the inflammation has a much 
larger extent compared to fracture, since additional involvement of exogenous factors induce 
cardiac dysfunction and multiple organ failure. Moreover, patients who died from sepsis often 
exhibit suppressed immune response, which makes translation to systemic condition of single 
long bone fracture difficult (72). Nevertheless, we think that the molecular mechanisms which 
affect the heart after single long bone fracture might be the same as after polytrauma or during 
sepsis. The absence of C5aR1/2 improved cardiac function in mice (15) during sepsis. Moreover, 
usage of an antibody with neutralizing activity to histone H2A and H4 ameliorated cardiac 
function in septic mice (20). Furthermore, inhibition of TNF production in endotoxemic rats 
preserved myocardial contractile function (73). Consequently, these cardio-depressive mediators 
are involved in development of cardiac dysfunction after trauma and during sepsis and might 
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also predispose to cardiac damage after long bone fracture. For sure, many other cytokines are 
systemically released after fracture such as IL-1, IL-6, IL-8, TGF and G-CSF, which further 
may contribute to cardiac alterations after fracture and to the development of cardiac dysfunction 
(74,75). 
In the present study, we treated human CMs with an inflammation cocktail, including the 
inflammatory cytokines IL-1, IL-6, IL-8 and TNF, as well as the anaphylatoxins C3a and C5a, 
which all have been shown to be elevated systemically after fracture. In the present study, the 
presence of the inflammation cocktail impaired mitochondrial respiration of the human 
cardiomyocytes and increased the amount of cellular ROS, which might be mediated via NLRP3 
inflammasome activation and IL-1 release. Since the observed effects of inflammation-cocktail 
on human cardiomyocytes were multifactorial and could be mediated through synergistic 
interactions, we selected the inflammatory TNF for the further experiments in order to specify 
the cardio-depressive effects of the single fracture-specific inflammatory cytokines. In the 
present study, presence of TNF increased the release of troponin I, extracellular histones as well 
as the amount of cytosolic ROS in human CMs in vitro. The caspase-3 activity as well as the 
number of apoptotic cells in left ventricles of pigs were not altered in the present study, 
indicating an apoptosis-independent release of troponin I after long bone fracture. This is in 
contrast to previous studies, which showed a correlation between myocardial TNF 
concentrations, cardiac dysfunction and CM apoptosis during sepsis as well as in chronic heart 
failure (13,12). Furthermore, incubation of CMs with plasma of mice receiving mechanical 
trauma increased apoptosis in cells, which was ameliorated in presence of an anti-TNF-antibody 
(76). Also, elevation of caspases 3, 8, 9 and the pro-apoptotic factor BCL-2 associated X protein 
(BAX) were described in isolated rat CMs in presence of IL-1ß and TNF (77). Therefore, the 
release of the cardio-depressive inflammatory cytokine TNF after isolated long bone fracture 
might contribute to the present cardiac structural alterations.  
One major limitation of this study is the age discrepancy between the pigs and the humans. 
Whilst the pigs are juvenile, the patients in this study are adult. These age differences may bias 
the data and should be always considered when investigating and interpreting cardiac function, 
cardiac morphology but also systemic inflammation after fracture. Consequently, further studies 
have to be performed with younger patients in order to determine cardiac alterations after 
fracture. Despite the age differences of the used species we were able to show indications for 
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cardiac alterations and cardiac injury in both species. Moreover, besides the difficulties in 
interpreting the data, the authors want to underline that one advantage of the present study is the 
comparison between the different species and models with regard to cardiac alterations after 
single long bone fracture.  
Summarized, in the present study we demonstrated systemic as well as local cardiac alterations 
after isolated long bone fracture. These alterations were linked to the systemic release of 
inflammatory mediators and DAMPs. Finally, the observed systemic as well as local cardiac 
alterations after isolated long bone fracture might predispose for secondary cardiac injury. 
However, this has to be addressed in more detail in future studies.  
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Figure 1: Systemic inflammation and release of extracellular histones after fracture in mouse, 
pig and human. (a) C5a concentration in plasma of mice with a fracture (#), compared to sham 
treated animals measured 6 hrs after fracture, n = 5-7. (b) C3a concentration in µg/ml in plasma 
of mice with a fracture (#), compared to sham treated animals measured 6 hrs after fracture, n = 
5-7. (c) TNF levels in µg/ml and (d) Il-6 levels in pg/ml in plasma of mice with fracture (Fx), 
compared to sham treated animals measured 6 hrs after fracture, n = 5-7. (e) extracellular histone 
appearance in plasma from mice (C57BL/6) 6 and 24 hrs after fracture or after sham treatment 
(f) Time course for extracellular histone appearance in serum from pigs after fracture (black bars, 
n = 48) compared to sham (white bars, n = 3). (g) Time course for extracellular histone 
appearance in plasma from patients with fracture (#), at day of fracture (0 d, n = 25) and 14 days 
after fracture (14 d, n = 6) (both black bars). (h) TNF concentration in pg/ml in plasma from 
patients with fracture (#), at day of fracture (0 d, n = 26) and 14 days after fracture (14 d) (both 
black bars, n = 7), compared to healthy controls (white bar) n = 20. (i) C5a concentration in 
plasma from patients with fracture (#), at day of fracture (0 d, n = 26) and 14 days after fracture 
(14 d, n = 7) (both black bars), compared to healthy controls (white bar), n = 20. *differences to 
sham/ baseline (BL)/ control procedure were significant, p<0.05. 
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Figure 2: Troponin I concentration in pig and human after fracture: (a)Time course of cardiac 
specific troponin I in ng/ml in serum of pigs after fracture (n = 8) compared to sham procedure (n 
= 3). (b) Apoptotic cells in percentage detected by TUNEL staining of left ventricle in sham (n = 
3) and after fracture and damage control treatment (DCO, n = 4) or early total care (ETC, n = 4) 
treatment. (c) Concentrations of cardiac troponin I in ng/ml in plasma of patients with fracture 
(#) at day of fracture (0 d, n = 26) and at day 14 after fracture (14 d, n = 7) compared to healthy 
controls (white bars, n= 20). Correlation analysis if systemic troponin I values (d). Systemic 
troponin I values (ng/ml) were correlated with the age of the patients. R
2
=0.003. * differences to 
control procedure were significant, p<0.05. 
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Figure 3: Structural alterations in the porcine heart after fracture: α-actinin, desmin and 
translocation of Cx43: (a) Flourescence intensity of α2-actinin staining and confocal imaging in 
animals treated with fracture and Damage Control Orthopedics (DCO, n = 4), or fracture and 
Early Total Care (ETC, n=4 ) compared to sham (n = 3). (b) Flourescence intensity of α2-desmin 
staining and confocal imaging in animals treated with fracture and Damage Control Orthopedics 
(DCO, n = 4), or fracture and Early Total Care (ETC, n=4) compared to sham (n = 3). (c) Results 
of density measurement of Connexin 43 (Cx43) staining in left ventricular tissue after fracture 
and DCO (n = 4) or ETC (n = 4) treatment and in sham treated animals (white bar, n = 3). (d) 
Representative distribution of Cx43 staining of the left ventricle of sham treated animals and pigs 
after fracture and damage control (DCO, middle) treatment and early total care (ETC, right), * 
differences to sham were significant, p<0.05.  
Copyright © 2020 by the Shock Society. Unauthorized reproduction of this article is prohibited.
 
 
Figure 4: Local inflammation: (a) Changes in density of C5aR1 staining in left ventricular tissue 
of pigs 72 hours after fracture, followed by DCO (n = 4) or ETC (n = 4) treatment as well as in 
sham treated pigs (n = 3). (b) mRNA expression of C5aR in left ventricles of pigs 72 hours after 
fracture and DCO (n = 4) or ETC treatment (n = 4) or sham procedure (n = 3) * differences to 
sham were significant, p<0.05.   
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Figure 5: In vitro influence of inflammation-cocktail (IF-C) or TNF (250 pg/ml) on human 
cardiomyocytes. (a) Mitochondrial respiration of human cardiomyocytes during MitoStress Assay, 
measured with Seahorse XFe96 Analyzer. Oxygen consumption rate (OCR) in pmol/min/Norm. Unit. 
Cells were treated for 6 hrs either with inflammation-cocktail (IF-C) or with 250 pg/ml TNF. Control 
group was only treated with cell culture medium. n=6. (b) Mitochondrial basal respiration of human 
cardiomyocytes. Oxygen consumption rate (OCR) in pmol/min/Norm. Unit. Cells were treated with 
inflammation cocktail (IF-C) or with 250 pg/ml TNF for 6 hrs. Control group was only treated with cell 
culture medium. Mitochondrial respiration was measured with MitroStress Assay using the Seahorse 
XFe96 Analyzer. n=6. (c) Mitochondrial spare respiratory capacity of human cardiomyocytes. Oxygen 
consumption rate (OCR) in pmol/min/Norm. Unit. Cells were treated with inflammation cocktail (IF-C) 
or with 250 pg/ml TNF for 6 hrs. Control group was only treated with cell culture medium. Mitochondrial 
respiration was measured with MitroStress Assay using the Seahorse XFe96 Analyzer. n=6. (d) 
Mitochondrial maximal respiration of human cardiomyocytes. Oxygen consumption rate (OCR) in 
pmol/min/Norm. Unit. Cells were treated with inflammation cocktail (IF-C) or with 250 pg/ml TNF for 6 
hrs. Control group was only treated with cell culture medium. Mitochondrial respiration was measured 
with MitroStress Assay using the Seahorse XFe96 Analyzer. n=6. (e) Reactive oxygen species (ROS) in 
human cardiomyocytes treated with inflammation-cocktail (IF-C) for 6 hrs and controls (control) assessed 
by Cell ROX® Red Reagent, n = 6. mRNA expression of IL-1 (f) and NLRP3 inflammasome (g) of 
human cardiomyocytes treated with inflammation-cocktail (IF-C). Control cells were only treated with 
cell culture medium. mRNA expression in fold change. * differences to control were significant, p<0.05. 
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Figure 6: In vitro influence of TNF (250 pg/ml) presence to human cardiomyocytes. (a) Troponin I 
concentration in ng/ml in supernatant (SN) of human cardiomyocytes treated with 250 pg/ml TNF for 6 
hrs compared to control cardiomyocytes measured by ELISA, n = 6. (b) Caspase 3 luminescence in 
counts/seconds measurement of human cardiomyocytes after incubation in absence (control) and in 
presence of 250 pg/ml TNF for 6 hrs (TNF), n = 6. (c) Appearance of extracellular histones in µg/ml in 
supernatant of human cardiomyocytes incubated with 250 pg/ml TNF for 6h compared to control 
cardiomyocytes, n = 6 measured by using ELISA. mRNA expression of IL-1ß (d), NLRP3 (e), Cx43 (f) 
and C5aR1 (g) of cardiomyocytes incubated in absence (control) and in presence of TNF for 6 hrs, n = 6. 
(h) Reactive oxygen species (ROS) in human cardiomyocytes treated with TNF (TNF) for 6 hrs and 
controls (control) assessed by Cell ROX® Red Reagent, n = 6, * differences to control were significant, 
p<0.05. 
Copyright © 2020 by the Shock Society. Unauthorized reproduction of this article is prohibited.
 
 
Figure 7: Effects of extracellular histones: (a) NET formation in human PMNs in percentage 
after treatment with different concentrations of histones (mix of histones) and LPS for 6 hrs 
compared to control -PMNs, n = 6. (b) extracellular DNA in percentage measured in PMNs 
treated with plasma of healthy controls (n = 4) and of patients with fracture (n = 6) for 2 h. (c) 
Troponin I concentration in supernatant of human cardiomyocytes treated with histones (6 hrs, 
12 hrs, 24 hrs, +) compared to untreated cardiomyocytes (-), n = 6. * differences to controls were 
significant p<0.05. 
 
 
